Icon of the Instituts for Quality and Efficiency in Health Care

Report

Biologic medications as second-line therapy for rheumatoid arthritis

Status
Status: Commission completed
Project no.
A10-01
Last updated

Report documents

  1. Executive summary of the final report

    Biologic medications as second-line therapy for rheumatoid arthritis

    published on
    Document type
    PDF-Dokument, 490 kB, EN, PDF
    Download file : Executive summary of the final report (PDF-Dokument, 490 kB, EN, PDF)

  2. Additional information on studies that were not included

    Biologic medications as second-line therapy for rheumatoid arthritis

    published on
    Document type
    PDF-Dokument, 25 kB, DE, PDF
    Download file : Additional information on studies that were not included (PDF-Dokument, 25 kB, DE, PDF)

  3. Final report

    Biologic medications as second-line therapy for rheumatoid arthritis

    published on
    Document type
    PDF-Dokument, 9 MB, DE, PDF
    Download file : Final report (PDF-Dokument, 9 MB, DE, PDF)

  4. Documentation and evaluation of comments on the preliminary report

    Biologic medications as second-line therapy for rheumatoid arthritis

    published on
    Document type
    PDF-Dokument, 10 MB, DE, PDF
    Download file : Documentation and evaluation of comments on the preliminary report (PDF-Dokument, 10 MB, DE, PDF)

  5. Executive summary of the preliminary report

    Biologic medications as second-line therapy for rheumatoid arthritis

    published on
    Document type
    PDF-Dokument, 441 kB, DE, PDF
    Download file : Executive summary of the preliminary report (PDF-Dokument, 441 kB, DE, PDF)

  6. Preliminary report

    Biologic medications as second-line therapy for rheumatoid arthritis

    published on
    Document type
    PDF-Dokument, 6 MB, DE, PDF
    Download file : Preliminary report (PDF-Dokument, 6 MB, DE, PDF)

  7. Report plan version 1.0

    Biologic medications as second-line therapy for rheumatoid arthritis

    published on
    Document type
    PDF-Dokument, 188 kB, DE, PDF
    Download file : Report plan version 1.0 (PDF-Dokument, 188 kB, DE, PDF)

  8. Documentation and appraisal of comments on the preliminary report plan

    Biologic medications as second-line therapy for rheumatoid arthritis

    published on
    Document type
    PDF-Dokument, 9 MB, DE, PDF
    Download file : Documentation and appraisal of comments on the preliminary report plan (PDF-Dokument, 9 MB, DE, PDF)

  9. Preliminary report plan

    Biologic medications as second-line therapy for rheumatoid arthritis

    published on
    Document type
    PDF-Dokument, 138 kB, DE, PDF
    Download file : Preliminary report plan (PDF-Dokument, 138 kB, DE, PDF)

Press releases

Rheumatoid arthritis: biologics in second-line therapy show benefit

Positive effects for all drugs / long-term data and robust direct comparisons are lacking
Press release

Additional information

IQWiG health information

Medication to prevent joint damage

Project details

Project no.
A10-01
Commission
Commission awarded on 20.05.2010 by the Federal Joint Committee (GBA).
Report type
Report
Status
Commission completed
Department/Division
Drug Assessment
Topic
Muscles, bones and joints

Contact

Press contact

+49 221 356850

press@iqwig.de

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form

Print page